IoT sensor networking provider SENSORO receives USD 18 M for Series B round
SENSORO
Founded in: 2013
Financing status: RMB 124 million (USD 18 million) Series B financing in 2017
SENSORO is an IoT sensor networking provider that is committed to the convergence of the physical and digital world through its sensor technologies. Founded in 2013 in Beijing, the company mainly manufactures two IoT sensor networking products.
The first product is its beacon devices that collect and send information based on wireless sensor networks, and it collects digital data from the physical world and then send it to its IoT applications.
The second product is the Alpha Product Suite. It provides low cost and low power capabilities for IoT networks. It is simple to manage the network that covers over 120 square miles while supporting thousands of sensor devices on its Alpha platform.
SENSORO previously received financing funding from Nokia Growth Partners, New World Strategic Investment and Mandra Capital. This Series C financing round was from Bosch, Sumitomo and Tsing Capital. The funds will be used to manufacture over 100,000 environmental related devices and 500,000 communication modules in 2017 to support infrastructure in cities, buildings, and so on.
AI-based medical image diagnosis system 12SIGMA receives tens of millions in USD for pre-Series A.
12SIGMA
Founder: Zhong Xin
Founded in: 2015
Financing status: Hundreds of millions in RMB (tens of millions in USD) for Series C financing in 2017
12SIGMA is a biotech company that integrates artificial intelligence and deep learning into modern medical image diagnosis and medical data analysis. Founded in 2015 in Beijing, the company has so far released two medical diagnosis products – deep learning networks and a cloud CAD diagnosis platform.
12SIGMA signed collaboration agreements with many top tier hospitals in Beijing, Shanghai and some other Chinese cities. Based on its medical image diagnosis system, it can assist doctors with the treatment process, and collect information and data on the effects of its system. It also reached a collaboration with some medical device vendors and manufacturers to integrate its medical diagnosis system with their products.
This pre-Series A financing round was led by K2VC, and with ZhenFund and Matrix Partners China joining as investors. The company plans to use this fund to develop automatic diagnostic products for cancer, cardiovascular disease and cerebrovascular disease.
(Top photo from Sensoro.com)
